Alcobra Ltd (ADHD)

1.12
NASDAQ : Health Care
Prev Close 1.10
Day Low/High 1.10 / 1.12
52 Wk Low/High 0.83 / 4.72
Avg Volume 75.80K
Exchange NASDAQ
Shares Outstanding 27.56M
Market Cap 30.32M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Alcobra Announces Leadership Update

Exodus Capital Is Summoning An Extraordinary General Meeting

Exodus Rejects Alcobra's Delaying Tactics

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Alcobra Ltd.

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Alcobra Ltd.

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Alcobra, Ltd., And Encourages Investors To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Alcobra, Ltd.

SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Alcobra, Ltd. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Alcobra, Ltd. And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Alcobra, Ltd.

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Alcobra, Ltd. And Advises Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Alcobra, Ltd. And Advises Investors With Losses To Contact The Firm

Goldberg Law PC announces that it is investigating Alcobra Ltd.

Alcobra Shares Plummet as ADHD Drug Fails

Alcobra Shares Plummet as ADHD Drug Fails

Alcobra has plans to restore shareholder value, but it's unclear what that plan will entail.

Alcobra Reports Phase 3 Clinical Trial Of MDX In Adults With ADHD Missed Primary Endpoint

Alcobra Reports Phase 3 Clinical Trial Of MDX In Adults With ADHD Missed Primary Endpoint

Management to hold a conference call & webcast today, January 17th at 8:00 a.m. EST

Alcobra Updates On Recent FDA Meeting

Alcobra Updates On Recent FDA Meeting

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

The imbalances in patient baseline characteristics provided an assist to Corbus' resunab treatment response and undermines the credibility of the trial results, a source says.